[Federal Register Volume 71, Number 35 (Wednesday, February 22, 2006)]
[Notices]
[Page 9136]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-1642]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Statement of Organization, Functions, and Delegations of 
Authority

    Part N, National Institutes of Health, of the Statement of 
Organization, Functions, and Delegations of Authority for the 
Department of Health and Human Services (HHS) (40 FR 22859, May 27, 
1975, as amended most recently at 69 FR 64081, November 3, 2004, and 
redesignated from Part HN as Part N at 60 FR 56606, November 9, 1995), 
is amended as set forth below to reflect the reorganization of the 
National Human Genome Research Institute, Division of Intramural 
Research, by establishing (1) the Molecular Neurogenetics Section in 
the Medical Genetics Branch and (2) the Vascular Biology Section in the 
Genome Technology Branch. The sections are transferring from, 
respectively, the National Heart, Lung, and Blood Institute and the 
National Institute of Mental Health.
    Section N-B, Organization and Functions, under the heading National 
Human Genome Research Institute (N4, formerly HN4), Division of 
Intramural Research (N45, formerly HN45) is amended as follows:
    (1) In the Genome Technology Branch (N455, formerly HN455), 
immediately after the paragraph on Genomic Functional Analysis Section 
(N4556, formerly HN 4556), insert the following:
    Vascular Biology Section (N4557, formerly HN 4557). Conducts 
clinical and laboratory investigations in the molecular mechanisms of 
cardiovascular disease including vascular cell biology, gene therapy, 
and cell cycle regulation of vascular cells.
    (2) In the Medical Genetics Branch (N456, formerly HN456), 
immediately after the paragraph on Vertebrate Embryology Section 
(N4567, formerly HN4567), insert the following:
    Molecular Neurogenetics Section (N4568, formerly HN 4568). (1) 
Conducts clinical and basic research into the factors contributing to 
the phenotypic variation observed in monogenic diseases, using Gaucher 
disease as a prototype disorder; (2) investigates the relationship 
between Gaucher disease and parkinsonism; and (3) explores new 
therapeutic approaches for Gaucher disease.

Delegations of Authority

    All delegations and redelegations of authority to officers and 
employees of NIH that were in effect immediately prior to the effective 
date of this amendment and are consistent with this amendment shall 
continue in effect, pending further redelegation.

    Dated: February 8, 2006.
Elias A. Zerhouni,
Director, National Institutes of Health.
[FR Doc. 06-1642 Filed 2-21-06; 8:45 am]
BILLING CODE 4140-01-M